Indivior Pharmaceuticals (INDV) Other Operating Expenses (2024 - 2026)

Indivior Pharmaceuticals' Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$1.0 million for Q1 2026.

• In Q1 2026, Other Operating Expenses changed 0.0% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$3.0 million (up 98.47% YoY), while the FY2025 annual figure was -$3.0 million, up 98.46% from the prior year.
• Other Operating Expenses was -$1.0 million for Q1 2026 at Indivior Pharmaceuticals, up from -$2.0 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $1.0 million in Q4 2024 to a low of -$160.0 million in Q2 2024.
• Historically, Other Operating Expenses has averaged -$33.2 million across 3 years, with a median of -$1.5 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses sank 300.0% in 2025, then changed 0.0% in 2026.
• A 3-year view of Other Operating Expenses shows it stood at $1.0 million in 2024, then tumbled by 300.0% to -$2.0 million in 2025, then surged by 50.0% to -$1.0 million in 2026.
• The last three Other Operating Expenses figures came in at -$1.0 million (Q1 2026), -$2.0 million (Q4 2025), and -$1.0 million (Q1 2025), per Business Quant data.